KLK3 and prostate carcinoma: A rapid decrease in the PSA level after PADT may be due to ablation of the androgen receptor function, and quick suppression of androgen/androgen receptor during PADT may have a negative effect on disease progression, because the androgen receptor can act as a tumor suppressor for prostate cancer [24].